-
1 Comment
Mach7 Technologies Limited is currently in a long term downtrend where the price is trading 12.5% below its 200 day moving average.
From a valuation standpoint, the stock is 94.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 15.3.
Mach7 Technologies Limited's total revenue sank by 21.8% to $7M since the same quarter in the previous year.
Its net income has dropped by 1163.1% to $-7M since the same quarter in the previous year.
Finally, its free cash flow fell by 199.8% to $-1M since the same quarter in the previous year.
Based on the above factors, Mach7 Technologies Limited gets an overall score of 1/5.
Exchange | AU |
---|---|
CurrencyCode | AUD |
ISIN | AU000000M7T0 |
Sector | Healthcare |
Industry | Health Information Services |
PE Ratio | None |
---|---|
Target Price | 0.7351 |
Beta | 1.6 |
Market Cap | 75M |
Dividend Yield | None |
Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients' medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. The company also provides workflow applications, such as a universal worklist, quality control (QC) tools designed for technologists' workflows; image sharing and exchange capabilities; teleradiology services; and additional specialized tools to serve departmental patient care needs. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for M7T.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025